IDEXX Laboratories, Inc. (idxx)

Unlock full data in Terminal →

IDXX — Company Overview

IDEXX Laboratories, Inc. (IDXX) is a large-cap company in the Healthcare sector, operating in Diagnostics & Research.

Ticker	IDXX
Sector	Healthcare
Industry	Diagnostics & Research
Exchange	NMS
Market cap	$41.13B
Last price	$522.02
Size category	Large Cap

IDXX — Business Description

IDEXX Laboratories, Inc. (IDXX) operates in Diagnostics & Research within the broader Healthcare market. IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dent…

Official website: https://www.idexx.com.

IDXX — Investment Thesis

The investment thesis for IDEXX Laboratories, Inc. (IDXX) rests on how Healthcare dynamics, profitability, and valuation interact at today's price.

Revenue is expanding at roughly 9.7% year-over-year (public data).
Trailing P/E of 36.28× implies elevated growth expectations at the current price.
Forward P/E (31.18×) is below trailing P/E — earnings may be expected to improve.
Equity market capitalization is approximately $41.13B.

See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.

IDXX — Financial Health

Financial health for IDEXX Laboratories, Inc. (IDXX) is summarized from publicly reported profitability, leverage, and cash-flow metrics.

Profit margin of 25.0% indicates solid bottom-line conversion. Positive free cash flow of $909.37M supports balance-sheet flexibility.

Trailing P/E	36.28×
Forward P/E	31.18×
Price / Sales	9.04×
Price / Book	25.53×
Gross margin	62.4%
Operating margin	35.0%
Profit margin	25.0%
Return on equity	74.2%
Debt / Equity	67.97
Free cash flow	$909.37M

IDXX — Growth Outlook

Growth outlook for IDEXX Laboratories, Inc. (IDXX) depends on demand trends in Diagnostics & Research and the company's ability to convert revenue into sustainable earnings.

Revenue growth of 9.7% suggests steady but measured expansion.
Earnings growth of 17.6% year-over-year supports improving profitability.
Price is 32.2% below the 52-week high.
Shares trade 4.3% above the 52-week low — limited rebound so far.

IDXX — Competitive Position

IDEXX Laboratories, Inc. (IDXX) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.

Competes within Healthcare, specifically in Diagnostics & Research.
Market capitalization of $41.13B places IDXX among large-cap peers.
Gross margin near 62.4% may reflect pricing power or favorable mix.

IDXX — Strengths

Strengths for IDEXX Laboratories, Inc. (IDXX) inferred from public financial metrics:

Revenue growth of 9.7% year-over-year.
Earnings growth of 17.6% year-over-year.
Return on equity near 74.2% — efficient use of shareholder capital.
Gross margin of 62.4% supports competitive unit economics.
Positive free cash flow ($909.37M).
Moderate leverage (debt/equity 67.97).

IDXX — Weaknesses

Weaknesses and pressure points for IDEXX Laboratories, Inc. (IDXX) based on available data:

Elevated trailing P/E (36.28×) limits valuation margin of safety.
High beta (1.54) amplifies market swings.
Price 32% below the 52-week high — sustained negative sentiment.

IDXX — Opportunities

Sustained revenue growth (9.7%) could support multiple expansion if margins hold.
Trading 4.3% above the 52-week low — potential recovery if fundamentals stabilize.
Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.

IDXX — Risks

Beta of 1.54 implies above-market volatility.

IDXX — Summary

IDEXX Laboratories, Inc. (IDXX) is a large-cap Healthcare company focused on Diagnostics & Research, listed on NMS. Last price $522.02 with market cap $41.13B. Trailing P/E 36.28×. Revenue grew 9.7% year-over-year per public data. Notable strengths include revenue growth of 9.7% year-over-year. Key watch items include elevated trailing p/e (36.28×) limits valuation margin of safety. Public estimates and earnings snapshots for IDEXX Laboratories, Inc. are on this site; ownership, live news, and deeper models remain in Vest Terminal.

Start Free — open IDXX in Vest Terminal

Access live data, filings, ownership, and analysis for IDEXX Laboratories, Inc..

Create free account See plans

IDEXX Laboratories, Inc. FAQ

What does IDEXX Laboratories, Inc. (IDXX) do?

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Q…

What is IDXX's P/E ratio?

IDEXX Laboratories, Inc. has a trailing P/E of 36.28× based on publicly available market data.

Does IDXX pay a dividend?

Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.

What sector is IDXX in?

IDEXX Laboratories, Inc. is classified in Healthcare (Diagnostics & Research) on NMS.

What is IDXX's market capitalization?

Approximate market cap: $41.13B.

What are the main risks for IDXX?

Key risks include above-average volatility (beta 1.54), elevated valuation, among factors on this page.

What are the strengths of IDXX?

Potential positives include revenue growth of 9.7% year-over-year, earnings growth of 17.6% year-over-year.

Where can I get analyst estimates for IDXX?

Public analyst price targets and consensus for IDEXX Laboratories, Inc. are on the free /stocks/idxx/estimates page. Deeper estimate history and models are available in Vest Terminal.